Business Segments · Selling, general, and administrative
Life Sciences: — Selling, general, and administrative
STERIS Life Sciences: — Selling, general, and administrative decreased by 3.1% to $15.60M in Q4 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ3 2024
Last reportedQ4 2025
Rolls up toSG&A
How to read this metric
Rising costs may indicate aggressive expansion or higher sales support needs, while declining costs relative to revenue suggest improved operational leverage.
Detailed definition
This metric represents the indirect operating expenses, including sales commissions, marketing, and administrative overh...
Peer comparison
Commonly reported as SG&A expense at the segment level for diversified medical technology firms.
Metric ID:
ste_segment_life_sciences_selling_general_and_administrativeHistorical Data
4 periods
| Q3 '24 | Q4 '24 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|
| Value | $14.70M | $15.00M | $16.10M | $15.60M |
| QoQ Change | — | +2.0% | +7.3% | -3.1% |
| YoY Change | — | — | +9.5% | +4.0% |
Range$14.70M – $16.10M
Avg YoY Growth+6.8%
Median YoY Growth+6.8%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is STERIS's life sciences: — selling, general, and administrative?
- STERIS (STE) reported life sciences: — selling, general, and administrative of $15.60M in Q4 2025.
- What does life sciences: — selling, general, and administrative mean?
- Operating expenses related to selling and administrative functions for the Life Sciences segment.